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Abstract
Background: Abl interactor (Abi) family proteins play significant roles in actin cytoskeleton organization through
participation in the WAVE complex. Mammals possess three Abi proteins: Abi-1, Abi-2, and NESH/Abi-3. Abi-1 and
Abi-2 were originally identified as Abl tyrosine kinase-binding proteins. It has been disclosed that Abi-1 acts as a
bridge between c-Abl and WAVE2, and c-Abl-mediated WAVE2 phosphorylation promotes actin remodeling. We
showed previously that NESH/Abi-3 is present in the WAVE2 complex, but neither binds to c-Abl nor promotes
c-Abl-mediated phosphorylation of WAVE2.
Results: In this study, we characterized NESH/Abi-3 in more detail, and compared its properties with those of Abi-1
and Abi-2. NESH/Abi-3 was ectopically expressed in NIH3T3 cells, in which Abi-1, but not NESH/Abi-3, is expressed. The
expression of NESH/Abi-3 caused degradation of endogenous Abi-1, which led to the formation of a NESH/Abi-3-based
WAVE2 complex. When these cells were plated on fibronectin-coated dishes, the translocation of WAVE2 to the plasma
membrane was significantly reduced and the formation of peripheral lamellipodial structures was disturbed,
suggesting that the NESH/Abi-3-based WAVE2 complex was unable to help produce lamellipodial protrusions.
Next, Abi-1, Abi-2, or NESH/Abi-3 was expressed in v-src-transformed NIH3T3 cells. Only in NESH/Abi-3-expressed cells
did treatment with an Abl kinase inhibitor, imatinib mesylate, or siRNA-mediated knockdown of c-Abl promote the
formation of invadopodia, which are ventral membrane protrusions with extracellular matrix degradation activity.
Structural studies showed that a linker region between the proline-rich regions and the Src homology 3 (SH3) domain
of Abi-1 is crucial for its interaction with c-Abl and c-Abl-mediated phosphorylation of WAVE2.
Conclusions: The NESH/Abi-3-based WAVE2 complex is functionally distinct from the Abi-1-based one, and
NESH/Abi-3 may be involved in the formation of ventral protrusions under certain conditions.
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Background
Abl interactor (Abi) family proteins are known to be in-
volved in regulation of the actin cytoskeleton. Mammals
possess three Abi proteins (Abi-1, Abi-2, and NESH/
Abi-3). The Abi-1 and Abi-2 proteins were first identi-
fied on yeast two-hybrid screening for proteins that inter-
act with a non-receptor tyrosine kinase, c-Abl [1, 2],
which is the proto-oncogene product of the Abelson
murine leukemia virus oncogene v-abl [3]. NESH/Abi-3
was identified as a new human gene that possesses a Src
homology 3 (SH3) domain [4], and was later added to the
Abi family based on the amino acid sequence similarity
[5]. The three Abi proteins possess substantially the same
domain structure, including an N-terminal WAVE-
binding (WAB) domain, several proline-rich regions, poly-
proline structures, and a C-terminal SH3 domain [5]. We
and other groups previously showed that Abi-1 promotes
the c-Abl-mediated phosphorylation of certain proteins
such as Mena [6], BCAP [7], Cdc2 [8], and WAVE2 [9],
suggesting its role in the regulation of Abl-mediated signal
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transduction. The regulation of c-Abl kinase activity by
Abi-1-derived phosphopeptides was also reported by
Xiong et al. [10]. Other studies showed that the Abi family
proteins are critical regulators of actin dynamics [11]. Abi-
1 and Abi-2, in particular, are present in a macromolecular
WAVE complex, which regulates Arp2/3-mediated actin
filament nucleation and actin network assembly in re-
sponse to Rac GTPase [12–15]. The WAVE complex is
composed of five proteins: WAVE, PIR121/Sra1, Nap1,
HSPC300, and Abi. Mammals possess three WAVE pro-
teins: WAVE1, 2, and 3. Binding studies indicated that
Abi-1 directly interacts with WAVE2 and Nap1, and
NAP1 interacts with PIR121/Sra1 [16]. Recent studies
showed that Abi-1 connects c-Abl to WAVE2 to permit c-
Abl-mediated WAVE2 phosphorylation. This promotes
the activation of the WAVE2 complex leading to the for-
mation of lamellipodial membrane protrusions [9]. Thus,
among the five components, Abi-1 and possibly Abi-2
serve as mediators that couple c-Abl-mediated signal
transduction and actin cytoskeleton reorganization.
Compared with those of Abi-1 and Abi-2, the function
of NESH/Abi-3 remains mostly unclear. Ichigotani et al.
reported that overexpression of NESH/Abi-3 in meta-
static cells suppressed cellular motility and the metasta-
sis potential [17]. Then, Matsuda et al. reported that
NESH/Abi-3 expression enhanced metastasis in the
presence of an Abl inhibitor, imatinib mesylate [18].
More recently, Bae et al. reported that NESH/Abi-3 dir-
ectly binds to F-actin, and regulates dendritic spine mor-
phogenesis and synapse formation in rat hippocampal
neurons [19, 20]. These results indicate that NESH/Abi-
3 is somehow involved in the regulation of the actin
cytoskeleton, but the mechanism remains elusive. In
addition, the similarities and differences among the three
Abi family proteins have not been fully defined. In this
context, we previously reported that NESH/Abi-3, like
Abi-1 and Abi-2, is present in the WAVE2 complex, but
neither binds to c-Abl nor promotes c-Abl-mediated
phosphorylation of WAVE2 [21].
In this study, we further examined the function of
NESH/Abi-3. Our results showed that the NESH/Abi-3-
based WAVE2 complex is functionally distinct from the
Abi-1-based one. We found another function of NESH/
Abi-3, i.e., in the formation of membrane protrusions in
v-Src-expressing cells.
Results
Ectopic expression of NESH/Abi-3 perturbed the
formation of lamellipodial protrusions
To identify a function of NESH/Abi-3, we first focused
on the WAVE2 complex because our previous study
showed that NESH/Abi-3 is included in the complex
[21]. The importance of the linkage between Abi-1 and
WAVE2 in the formation of lamellipodial protrusions
has been reported [9, 22]. The level of expression of
NESH/Abi-3 is very low in NIH3T3 cells (Additional file 1:
Figure S1a). Accordingly, FLAG-tagged NESH/Abi-3 was
stably expressed in NIH3T3 cells using a recombinant
retrovirus and then cell spreading on a fibronectin (FN)-
coated plate was examined (Fig. 1a). At 15 min after the
plating, both control and NESH/Abi-3-expressing NIH3T3
cells were attached to the dishes and filopodial membrane
protrusions were observed. At 30 min, control cells had la-
mellipodial membrane protrusions around their periphery
and were well spread on the dish (Fig. 1a, top right image).
By contrast, the NESH/Abi-3-expressing cells did not ex-
hibit lamellipodial protrusions and were poorly spread on
the dish at 30 min. (bottom right image). FLAG-tagged
Abi-1- or Abi-2-expressing cells exhibited a cell spreading
pattern similar to that of the control cells (second and
third row images), suggesting that the effect was specific to
NESH/Abi-3. Quantitative analysis supported this view-
point (Fig. 1b). Rac GTPase regulates the formation of
lamellipodial structures [23]. We then examined Rac activ-
ity in the NESH/Abi-3-expressing cells. The CRIB domain,
which specifically binds to activated Rac (i.e., a GTP-
binding form), was used to precipitate the activated Rac
from cell lysates. As shown in Additional file 1: Figure S1f,
a significant amount of activated Rac was detected at
15 min after plating for both control and NESH/Abi-3-ex-
pressing NIH3T3 cells. No significant differences were ob-
served between the two types of cells, suggesting that the
signaling pathway leading to Rac activation may not be
disturbed upon the expression of NESH/Abi-3. Leng et al.
reported that WAVE2 and c-Abl were translocated to
the cell periphery upon stimulation by FN, and that
their locations are important for the formation of la-
mellipodial protrusions and cell spreading [9]. We
thus examined the localization of endogenous WAVE2
in the control and NESH/Abi-3-expressing NIH3T3
cells after plating. As shown in Fig. 1c, WAVE 2 was
localized to the plasma membrane of the control cells
(top row images), but not that of the NESH/Abi-3-ex-
pressing cells (second row images). Meanwhile, Arp3
was localized to the cell periphery in both the control
and NESH/Abi-3-expressing NIH3T3 cells (third and
bottom row). These results suggest that WAVE2 was
not properly localized to the cell periphery in the
NESH/Abi-3-expressing cells after plating.
The actin cytoskeleton in NESH/Abi-3-expressing
NIH3T3 cells looked normal overnight after plating
(Fig. 1d). We then examined the lateral motility of
cells by using a wound healing assay (Fig. 1e). Here,
the expression of NESH/Abi-3 did not inhibit migra-
tion of NIH 3T3 cells. This result differed from those
obtained using v-src-tranformed NIH3T3 cells, in
which the expression of NESH/Abi-3 inhibits cell mo-
tility (17, Fig. 4b). We discuss the difference in the
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Discussion section. To exclude the possibility that the
FLAG-tag affected the results, we obtained NIH3T3
cells expressing Abi-1 or NESH/Abi-3 without any
tag. In terms of the formation of the lamellipodial
structures after plating and the lateral cell motility,
similar results were obtained using the non-tagged
proteins (Additional file 1: Figure S1b–d).
NESH/Abi-3-based WAVE2 complex
The above results prompted us to examine the WAVE2
complex in NESH/Abi-3-expressing cells. We first checked
endogenous expression of its components: WAVE2, Abi-1,
and PIR121/Sra1 (Fig. 2a). These proteins were detected in
the control cells (left column). In the NESH/Abi-3-ex-
pressing NIH3T3 cells, the expression levels of WAVE2
Fig. 1 NESH/Abi-3 expression impaired WAVE2 membrane translocation and cell spreading. (a) Control NIH3T3 cells, and NIH3T3 cells expressing
FLAG-Abi-1, FLAG-Abi-2, or FLAG-NESH were plated onto FN-coated coverslips. At the indicated times, the cells were fixed and stained with
TRITC-phalloidin. (b) Quantitative analysis of cells in (a). Cells with lamellipodial structures were counted under a fluorescence microscope. At least
100 cells were analyzed for each sample. Data represent the means ± S.D. for three independent experiments. Error bars represent S.D. ***, P < 0.001,
Student's t test. (c) The control and FLAG-NESH-expressing NIH3T3 cells were plated onto FN-coated coverslips. One hour after plating, the cells were
fixed and stained with an anti-FLAG antibody, TRITC-phalloidin, an anti-WAVE2, or an anti-Arp3 antibody. The right panels show merged views of the
TRITC-phalloidin and WAVE2 or Arp3 stained images. (d) The control and FLAG-NESH-expressing NIH3T3 cells were plated onto FN-coated coverslips.
After overnight incubation, the cells were fixed and stained with TRITC-phalloidin. (e) The wound-healing assay was performed, and the migration area
was quantified as described under Materials and Methods. Data represent the means ± S.D. for three independent experiments. The value for the
control cells was set to 100 %. Error bars represent S.D. *, P < 0.05; n.s., the difference was not significant, Student's t test
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and PIR121/Sra1 were verified, but the amount of Abi-1
protein was markedly decreased compared with that in the
control cells. The amount of Abi-2 protein also decreased
in NESH/Abi-3-expressing cells (Fig. 2a, bottom row). Be-
cause the expression level of Abi-2 was relatively low in
NIH3T3 cells (Additional file 1: Fig. S1a), we focused on
Abi-1 and NESH/Abi-3 in NIH3T3 cells. To investigate
the WAVE2 complex in the control and NESH/Abi-3-ex-
pressing NIH3T3 cells, we immunoprecipitated Abi-1 or
NESH/Abi-3 (Fig. 2b). Abi-1 was precipitated using an
anti-Abi-1 antibody from the control and NESH/Abi-3-ex-
pressing NIH3T3 cell lysates (lanes 3 and 8). As expected,
little Abi-1 was precipitated from the NESH/Abi-3-ex-
pressing NIH3T3 cell lysates (lane 8). WAVE2 and
PIR121/Sra1 were co-precipitated with Abi-1 from the
control cell lysates (lane 3, first and second rows), and
their precipitation was markedly reduced when the
NESH/Abi-3-expressing NIH3T3 cell lysates were used
(lane 8, first and second rows). NESH/Abi-3 was precipi-
tated with an anti-NESH/Abi-3 antibody (lanes 4 and 9)
or an anti-FLAG antibody (lanes 5 and 10). Both WAVE2
and PIR121/Sra1 were co-precipitated with NESH/Abi-3
from the NESH/Abi-3-expressing NIH3T3 cell lysates. A
control mouse IgG was not precipitated with any of
PIR121/Sra1, WAVE2, Abi-1, and NESH/Abi-3 from ei-
ther cell lysates (lanes 2 and 7). As mentioned above,
Abi-1 directly binds to WAVE2, but not to PIR121/
Sra1, so the precipitation of PIR121/Sra1 with an anti-
body against each Abi protein indicated the formation
of a WAVE2 complex. Thus, the results suggest the for-
mation of a NESH/Abi-3-based WAVE2 complex in the
NESH/Abi-3-expressing NIH3T3 cells.
To clarify whether or not the Abi-1-based and NESH/
Abi-3-based WAVE2 complexes exist independently, we
examined mouse brain and HUVEC lysates, each con-
taining significant amounts of NESH/Abi-3 as well as
Abi-1. We immunoprecipitated Abi-1 or NESH/Abi-3
by using specific antibodies (Fig. 3a). From mouse brain
lysates, WAVE2 and PIR121/Sra1 were co-precipitated
with Abi-1 and NESH/Abi-3 (lanes 3 and 4). When an
anti-Abi-1 antibody was used, no NESH/Abi-3 was co-
precipitated (lane 3, fourth row). However, it was not
clear whether or not Abi-1 was co-precipitated with an
anti-NESH/Abi-3 antibody (lane 4, third row). A thick
smear band was detected near the position of Abi-1 on
the blot. This was partly because the anti-NESH/Abi-3
mouse monoclonal antibody used for the precipitation
was detected with an anti-mouse secondary antibody. A
Fig. 2 Ectopically expressed NESH/Abi-3 was incorporated into the WAVE2 complex. (a) Twenty μg aliquots of lysates prepared from the control
and FLAG-NESH-expressing cells were analyzed by Western blotting with the indicated antibodies. For Abi-2, data regarding 100 μg aliquots of
lysates are also shown because no signal was found when 20 μg aliquots were used. (b) The lysates of the control and FLAG-NESH-expressing cells
were immunoprecipitated with mouse IgG, an anti-Abi-1 (1G9), an anti-NESH (2H7), or an anti-FLAG (M2) antibody. The precipitated proteins were
analyzed by Western blotting with the indicated antibodies. To confirm the NESH precipitation, a rabbit anti-human NESH antibody was also used
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control mouse IgG did not precipitate PIR121/Sra1,
WAVE2, Abi-1, or NESH/Abi-3 (lane 2). For HUVEC
cells, we used an anti-NESH/Abi-3 rabbit polyclonal
antibody for the immunoprecipitation, this antibody
reacting with human NESH/Abi-3 (Fig. 3a, right panels).
In the HUVEC cells, both Abi-1 and NESH/Abi-3 co-
precipitated WAVE2 and PIR121/Sra1 (lanes 7 and 10).
At this time, co-precipitation of Abi-1 and NESH/Abi-3
was not detected using either the anti-Abi-1 antibody
(lane 7) or the anti-NESH antibody (lane 10). This
clearly indicated that the NESH/Abi-3-based WAVE2
complex was independent of the Abi-1-based one. The
interaction of c-Abl with the WAVE complex was re-
ported by others [9, 22]. We then examined the binding
of c-Abl to either the Abi-1-based or NESH/Abi-3-based
WAVE2 complex. However, we were unable to detect
the co-precipitation of c-Abl with the anti-Abi-1 or anti-
NESH/Abi-3 antibody from brain lysates (Additional file 1:
Figure S1e), suggesting that the interaction might be transi-
ent and/or unstable.
Meanwhile, Fan et al. reported the oligomeric charac-
ter of Abi-1 [24]. To determine whether or not Abi-1
Fig. 3 Abi-1-based and NESH/Abi-3-based WAVE2 complexes exist independently. (a) Lysates prepared from mouse brain were immunoprecipitated
with a mouse IgG, an anti-Abi-1 monoclonal antibody (1G9), or an anti-NESH monoclonal antibody (2H7) (lanes 2 to 4). Lysates prepared from HUVEC
were immunoprecipitated with the mouse IgG, the anti-Abi-1 monoclonal antibody (1G9), a rabbit IgG, or a rabbit anti-human NESH antibody
as indicated (lanes 6, 7, 9, and 10). The precipitated proteins were analyzed by Western blotting with the indicated antibodies. A rabbit
anti-mouse NESH antibody was used to detect NESH in the mouse brain lysates (lanes 1 to 4). The rabbit (lanes 5 to 7) or mouse (lanes 8 to 10)
anti-human NESH antibody was used to detect NESH in the HUVEC lysates. (b) FLAG-Abi-1 or FLAG-NESH was coexpressed with GST-Abi-1, GST-NESH,
or GST in 293 T cells. GST-Abi constructs were pulled down with glutathione beads, and then the bound proteins were detected by Western blotting
with an anti-FLAG or GST antibody (pull-down). To determine the amounts of the proteins expressed, 4 % of each lysate was analyzed (4 % Input)
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interacts with NESH/Abi-3, we examined 293 T cells ex-
pressing both proteins. Abi-1 and NESH/Abi-3 were
tagged with either a FLAG or GST. The GST-tagged
proteins were precipitated with glutathione beads and
co-precipitation was assessed with the anti-FLAG anti-
body (Fig. 3b). FLAG-Abi-1 was co-precipitated with
GST-Abi-1 (lane 7), suggesting oligomerization of Abi-1.
No FLAG-Abi-1 was co-precipitated with GST-NESH/
Abi-3 (lane 8). Likewise, FLAG-NESH/Abi-3 was co-
precipitated with GST-NESH/Abi-3 (lane 11), but not
with GST-Abi-1 (lane 10). GST was precipitated with
neither FLAG-Abi-1 (lane 9) nor FLAG-NESH/Abi-3
(lane 12). These results indicated that Abi-1 and NESH/
Abi-3 are independent of each other as to the formation
of an oligomer, supporting the idea that Abi-1 and
NESH/Abi-3 create distinct WAVE2 complexes. Collect-
ively, our results suggest that the NESH/Abi-3-based
WAVE2 complex, which was produced in the NESH/
Abi-3 expressing cells, cannot be localized to the cell
periphery upon FN stimulation in order to produce the
lamellipodial protrusions.
NESH/Abi-3 promoted invadopodia formation in an
imatinib-dependent manner
Although Abi-1 promotes c-Abl-mediated phosphoryl-
ation, NESH/Abi-3 does not [21]. Hence, Abi-1 and
NESH/Abi-3 may have different functions in the c-Abl-
mediated signaling pathway. To examine the function of
NESH/Abi-3, we next used an Abl kinase inhibitor (ima-
tinib mesylate, Gleevec) to treat v-src-transformed
NIH3T3 cells (SRD cells). This is because Matsuda et al.
reported that vascular metastasis, which was assessed by
observing lung colonization after tail vein injection, was
elevated with imatinib mesylate-treatment in NESH/
Abi-3-expressing SRD cells [18]. We thus expressed the
three Abi family proteins in the SRD cells so as to com-
pare the phenotypes among the Abi family proteins. The
expression of Abi-1, Abi-2, and NESH/Abi-3 in the SRD
cells was first verified (Fig. 4a). Similar to in the case of
NIH3T3 cells, the level of expression of the Abi-1 pro-
tein was remarkably reduced in NESH/Abi-3-expressing
SRD cells (Fig. 4a, top row, lane 4). We next examined
lateral cell motility by using a wound healing assay. As
shown in Fig. 4b, SRD cells expressing NESH/Abi-3, but
not Abi-1 or Abi-2, showed somewhat reduced motility
compared with the parent SRD cells. Imatinib-treatment
reduced the motility of the control SRD cells, and also
that of Abi-1- Abi-2, or NESH/Abi-3-expressing SRD
cells, suggesting that the imatinib-treatment similarly
inhibited cellular lateral motility. We then examined
invadopodia formation (Fig. 4c, d and e). Invadopodia
are actin-rich ventral membrane protrusions, which pos-
sess extracellular matrix-degrading activity, and are sup-
posed to be involved in cancer cell invasion [25].
Cortactin is a well-known marker for invadopodia. Inva-
dopodium precursors are punctate, non-degrading
cortactin-rich structures, whereas mature invadopodia
are structures that can degrade the extracellular matrix
[26]. SRD cells expressing Abi-1, Abi-2, or NESH/Abi-3
were seeded onto a plate coated with fluorescently la-
beled gelatin and then cultured. After 7 h, the cells were
fixed and the number of cells exhibiting punctate cortac-
tin staining was determined (Fig. 4c). In Fig. 4d and e,
the gelatin degradation area was measured. When the
control SRD cells were treated with increasing amounts
of imatinib, the number of cells with cortactin dots as
well as the degradation area decreased, suggesting that
c-Abl-mediated phosphorylation is involved in the for-
mation of invadopodia, as reported previously [27]. Abi-
1- or Abi-2-expressing SRD cells showed substantially
the same levels of invadopodia formation as the parent
SRD cells, and the imatinib-treatment suppressed the
invadopodia formation. In contrast to these two cases,
the ectopic expression of NESH/Abi-3 suppressed the
invadopodia formation. It should be noted that the
imatinib-treatment remarkably increased the invadopo-
dia formation of the NESH/Abi-3-expressing SRD cells.
To determine whether or not the observed effects were
definitely due to the inhibition of c-Abl kinase, we
knocked down c-Abl in Abi-1- Abi-2, or NESH/Abi-3-
expressing SRD cells and then analyzed the invadopodia
formation. As shown in Fig. 4f and g, the knockdown of
c-Abl suppressed the invadopodia formation by Abi-1-
or Abi-2-expressing SRD cells. In addition, the treatment
increased the invadopodia formation by the NESH/Abi-
3-expressing SRD cells, although it was not marked
when compared with in the case of imatinib-treatment.
These results indicate that the expression of NESH/Abi-
3, but not Abi-1 or Abi-2, increased invadopodia forma-
tion when c-Abl was inhibited, suggesting that NESH/
Abi-3 has a different role from that of Abi-1 and Abi-2
in the c-Abl-mediated signaling pathway and the invado-
podia formation.
Chimeric analyses
To elucidate the structural difference between Abi-1 and
NESH/Abi-3, we created a series of chimeric mutants
between Abi-1 and NESH/Abi-3 (Fig. 5a). The activity of
c-Abl is normally suppressed through an autoinhibitory
mechanism [28], and interaction with partner proteins is
involved in the regulation of its activity [29]. Dai and
Pendergast [2] used a series of deletion mutants to
analyze Abi-2 regions that are involved in the interaction
with c-Abl. Their results revealed that the most N-
terminal proline-rich region and the SH3 domain of
Abi-2 are both involved in the interaction with c-Abl.
We first examined whether or not the intrinsic SH3 do-
main of Abi-1 is essential for the binding to c-Abl.
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Fig. 4 (See legend on next page.)
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Expression plasmids for c-Abl and FLAG-tagged
chimeras were cotransfected into 293 T cells. The cell
lysates were subjected to immunoprecipitation using an
anti-c-Abl antibody (Fig. 5b). The results demonstrated
that c-Abl was co-precipitated with the Abi-1/
NESH•SH3 mutant but not with the NESH/Abi-1•SH3
one. This finding showed that the SH3 domain of Abi-1
was functionally replaced by the SH3 domain of NESH/
Abi-3, and that the SH3 domain of Abi-1 alone was
insufficient for the binding to c-Abl. Next, we used
proline-rich-region-swapping mutants to determine
which proline-rich regions are involved in the binding
between c-Abl and Abi-1. Chimera N-1 contained the
WAB domain of NESH/Abi-3, and Chimeras N-2, N-3,
and N-4 included the most N-terminal, N-terminal two,
and N-terminal three proline-rich regions derived from
NESH/Abi-3, respectively (Fig. 5a). As shown in Fig. 5c
(lanes 1–4), c-Abl co-precipitated Chimeras N-1 to N-4.
However, the coprecipitation of Chimera N-5 was mark-
edly reduced, suggesting the difference between Chimera
N-4 and Chimera N-5 was significant with respect to
their binding to c-Abl. The difference comprises trunca-
tion of Abi-1 amino acids 270 to 336. Unexpectedly, this
region contains no proline-rich motif. To further verify
the functional significance of the interaction, we exam-
ined Abi-1-induced WAVE2 phosphorylation by c-Abl.
We coexpressed c-Abl, GST-WAVE2, and each of the
mutants in 293 T cells, and then examined the tyrosine
phosphorylation of GST-WAVE2 (Fig. 5d). Specifically,
when c-Abl and GST-WAVE2 were coexpressed with
the Abi-1 WT (lane 2) or Abi-1/NESH•SH3 mutant
(lane 3), the tyrosine phosphorylation of GST-WAVE2
was observed. However, when c-Abl and GST-WAVE2
were coexpressed with the NESH/Abi-3 WT (lane 4) or
NESH/Abi-1•SH3 mutant (lane 5), no tyrosine phos-
phorylation of GST-WAVE2 was observed. Coexpression
of each of Chimeras N1 to N4 promoted the tyrosine
phosphorylation of GST-WAVE2 (lanes 6 to 9), although
Chimera N-4 induced a slightly reduced level of
phosphorylation (lane 9). Interestingly, coexpression of
Chimera N-5 did not induce the phosphorylation of
GST-WAVE2 (lane 10). This pattern of phosphorylation
is consistent with the pattern of binding between c-Abl
and each of the mutants. We then examined the cellular
spreading of NIH3T3 cells expressing Chimera N-1
or N-5. Thirty minutes after plating, cells expressing
Chimera N-1, but not Chimera N-5, produced lamelli-
podial protrusions (Fig. 5e). This result also suggests that
Chimera N-5 behaves like NESH/Abi-3.
These results suggest the importance of amino acids
270 to 336 of Abi-1. We thus created a NESH/Abi-3
mutant that possesses amino acids 270 to 336 of Abi-1.
Amino acids 270 to 336 of Abi-1 were inserted immedi-
ately after the third proline-rich region of NESH/Abi-3,
and the resulting mutant was examined for the binding
to c-Abl and the promotion of c-Abl-mediated phos-
phorylation of WAVE2. As shown in Fig. 5f and g, the
mutant very slightly bound to c-Abl, and partially res-
cued the phosphorylation of WAVE2 by c-Abl, suggest-
ing the importance of this region. Figure 5h shows the
superimposed structures of Abi-1 and NESH/Abi-3, the
structures being constructed by computer modeling.
The two structures were similar to each other in terms
of the SH3 domain (residues 392 to 451 of Abi-1 and
residues 311 to 366 of NESH/Abi-3). The root-mean-
square deviation (RMSD) for Cα atoms in this domain
was 0.10 Å. This is consistent with our results demon-
strating that the SH3 domains of Abi-1 and NESH/Abi-
3 are interchangeable. The modeling results also demon-
strated that the structures of the WAB domains were
quite similar in the two proteins, suggesting that the
structural difference between Abi-1 and NESH/Abi-3 is
mainly due to the region between the WAB domain and
the SH3 domain. Interestingly, the distance between the
centers of the most N-terminal proline-rich region and
the SH3 domain was 84.5 Å for Abi-1 and 76.2 Å for
NESH/Abi-3 in this model. We also examined another
mutant in which tyrosine 213 of Abi-1 was replaced by a
(See figure on previous page.)
Fig. 4 NESH/Abi-3 promoted invadopodia formation in the presence of imatinib. (a) Lysates were prepared from SRD cells, and SRD cells expressing
Abi-1, FLAG-Abi-2, or NESH. Western blotting analysis was performed with the indicated antibodies. (b) The wound-healing assay was performed, and
the migration area was quantified as described under Materials and Methods. Data represent the means ± S.D. for three independent experiments.
Error bars represent S.D. The value for the control SRD cells was set to 100 %. *, P < 0.05; ***, P < 0.001, Student's t test. (c) The indicated cells were
plated onto TRITC gelatin-coated dishes. After 7 h, cells were fixed and stained with an anti-cortactin antibody. Cells with a punctate cortactin-rich
structure were counted under a fluorescence microscope. At least 100 cells were analyzed for each sample. Data represent the means ± S.D. for three
independent experiments. Error bars represent S.D. **, P < 0.005; ***, P < 0.001, Student's t test. (d) Invadopodia degradation areas were quantified as
described under Materials and Methods. For each sample, five cells exhibiting invadopodia degradation were randomly picked up and the degradation
area/cell area was calculated. Data represent the means ± S.D. for three independent experiments. Error bars represent S.D. **, P < 0.005; ***, P < 0.001,
Student's t test. (e) Representative confocal microscopy images of SRD cells, and SRD cells expressing Abi-1, FLAG-Abi-2, or NESH in (D). The black dots
indicate the invadopodia-mediated gelatin degradation. (f, g) SRD cells and SRD cells expressing Abi-1, FLAG-Abi-2, or NESH were treated with the
c-Abl siRNA for 72 h, and then analyzed as described in (c) and (d). (f) The percentage of cells containing a punctate cortactin-rich structure.
(g) Quantification of the degradation area. Data represent the means ± S.D. for three independent experiments. Error bars represent S.D. *, P < 0.05;
**, P < 0.005; ***, P < 0.001; n.s., the difference was not significant (P = 0.062 in (f), P = 0.17 in (g)), Student's t test
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Fig. 5 (See legend on next page.)
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phenylalanine, because tyrosine 213 of Abi-1 is report-
edly phosphorylated by c-Abl and by BCR-Abl [10, 30].
In our system, this mutant and Abi-1 both bound to
c-Abl and promoted the phosphorylation of WAVE2
by c-Abl in substantially the same manner (Fig. 5f, lane 5,
and Fig. 5g, lane 5). NESH/Abi-3 does not have a tyrosine
residue corresponding to the tyrosine 213 of Abi-1. But
the absence of the corresponding phosphorylation in
NESH/Abi-3 alone may not account for why NESH/Abi-3
does not regulate c-Abl-mediated phosphorylation of
WAVE2.
Discussion
In this study, we examined the roles of NESH/Abi-3 in
the formation of membrane protrusions, lamellipodia
and invadopodia. Our results suggest that NESH/Abi-3
plays a distinct role in the regulation of the actin cyto-
skeleton reorganization when compared with Abi-1 and
Abi-2.
Several studies showed that depletion of Abi-1 leads
to degradation of the WAVE2 complex. For example,
siRNA-mediated knockdown of Abi-1 caused degradation
of WAVE2 and other complex components [13, 31]. In
fibroblasts derived from Abi-1 knockout mice, the pro-
tein levels of WAVE2, PIR121/Sra1, and Nap1 were
significantly decreased [32]. In this study, we showed
that expression of NESH/Abi-3 in NIH3T3 cells caused
a marked reduction in the protein level of endogenous
Abi-1. Differing from in the case of Abi-1 knockdown
or knockout, the protein levels of WAVE2 and PIR121/
Sra1 did not change, and a WAVE2 complex containing
NESH/Abi-3 was formed, suggesting NESH/Abi-3 took
the place of Abi-1. Our immunoprecipitation study
showed that Abi-1 and NESH/Abi-3 are mutually ex-
clusive and create distinct WAVE2 complexes. Trans-
location of WAVE2 to the cell periphery was decreased
in the NESH/Abi-3-expressing cells. Leng et al. re-
ported the importance of the c-Abl-mediated WAVE2
phosphorylation for driving actin polymerization [9].
As reported previously, Abi-1, but not NESH/Abi-3,
promoted the WAVE2 phosphorylation by c-Abl [21].
The lack of the WAVE2 phosphorylation may lead to a
reduction in the formation of lamellipodial protrusions.
To support this idea, Chimera N-5, which lacks
the ability to promote the WAVE2 phosphorylation,
showed reduced lamellipodial formation (Fig. 5e).
Meanwhile, we tried to detect endogenous phosphoryl-
ation of WAVE2 in the control NIH3T3 cells, but
failed. The phosphorylation may occur transiently or be
very low in NIH3T3 cells. As another possibility, Abi-1,
but not NESH/Abi-3, might serve as a scaffold for pro-
teins that support the formation of membrane protru-
sions. It was reported that the interaction between c-Abl
and Abi-1 is important for the regulation of proteins such
as p85, a PI3-kinase subunit [33], and CAS [34]. PIP3 has
been reported to be necessary for WAVE2 translocation
(See figure on previous page.)
Fig. 5 Analysis of Abi-1/NESH chimeras. (a) Schematic representation of the chimeric proteins. Abi-1 (red) and NESH (blue), and the chimeric proteins
used in this study are schematically illustrated. The positions of the WAVE-binding (WAB) domain, the proline-rich region (PXXP motif), the polyproline
structure (pps), and the SH3 domain are indicated. (b) FLAG-Abi-1/NESH•SH3 or FLAG-NESH/Abi-1•SH3 was coexpressed with c-Abl in 293T cells. A
mouse IgG or an anti-c-Abl antibody was added to lysates of the transfected cells, and the precipitated proteins were analyzed by Western blotting
with antibodies against c-Abl and FLAG. To determine the amounts of the proteins expressed, 2 % of each lysate was analyzed (2 % Input).
(c) FLAG-chimera N-1 (lane 1), FLAG-chimera N-2 (lane 2), FLAG-chimera N-3 (lane 3), FLAG-chimera N-4 (lane 4), or FLAG-chimera N-5 (lane 5)
was coexpressed with c-Abl in 293T cells. c-Abl was immunoprecipitated with the anti-c-Abl antibody, and the precipitated proteins were
analyzed as described in (B). (d) 293T cells were cotransfected with expression plasmids for c-Abl and GST-WAVE2, together with an expression plasmid
for FLAG (lane 1), FLAG-Abi-1 wild-type (lane 2), FLAG–Abi-1/NESH•SH3 (lane 3), FLAG-NESH wild-type (lane 4), FLAG–NESH/Abi-1•SH3
(lane 5), FLAG-chimera N-1 (lane 6), FLAG-chimera N-2 (lane 7), FLAG-chimera N-3 (lane 8), FLAG-chimera N-4 (lane 9), or FLAG-chimera
N-5 (lane 10). The resulting cell lysates were analyzed by Western blotting with each of the antibodies against phosphotyrosine (α-pY),
c-Abl, FLAG, and GST. The expression of the wild-type Abi-1 and Abi-1/NESH•SH3 was below the respective detection limit in this assay.
However, the phosphorylation of GST-WAVE2 was evident in these cell lysates. The phosphorylated Abi-1 may have been subjected to
degradation. (e) NIH3T3 cells expressing Chimera N-1 or Chimera N-5 were plated onto FN-coated coverslips. At the indicated times, the
cells were fixed and stained with TRITC-phalloidin (left panels). Cells with lamellipodial structures were counted under a fluorescence
microscope. At least 100 cells were analyzed for each sample. Data represent the means ± S.D. for three independent experiments. Error
bars represent S.D. (the right graph) (f) FLAG (lane 1), FLAG-Abi-1 (lane 2), FLAG-NESH (lane 3), FLAG-NESH-Abi-1(a.a. 270–336) (lane 4), or
FLAG-Abi-1 Y213F (lane 5) was coexpressed with c-Abl in 293T cells. c-Abl was immunoprecipitated with an anti-c-Abl antibody, and the
precipitated proteins were analyzed as described in (b). To determine the amounts of the proteins expressed, 2 % of each lysate was analyzed
(2 % Input). The expression levels of FLAG-Abi-1 and FLAG-Abi-1 Y213F were low compared with those of FLAG-NESH and FLAG-NESH-Abi-
1(a.a. 270–336). However, the precipitation of FLAG-Abi-1 and FLAG-Abi-1 Y213F was evident in these cell lysates. (g) 293T cells were
cotransfected with expression plasmids for c-Abl and GST-WAVE2, and together with an expression plasmid for FLAG (lane 1), FLAG-Abi-1 (lane 2),
FLAG-NESH (lane 3), FLAG-NESH-Abi-1(a.a. 270–336) (lane 4), or FLAG-Abi-1 Y213F (lane 5). The GST-WAVE2 was pulled down with glutathione beads
and analyzed by Western blotting with the antibodies against a phosphotyrosine and GST. To determine the amounts of proteins expressed, 4 % of
each lysate was analyzed by Western blotting with the antibodies against c-Abl and FLAG (4 % Input). The expression of FLAG-Abi-1 and FLAG-Abi-1
Y213F was below the detection limit in this assay. However, the phosphorylation of GST-WAVE2 was evident in these cell lysates. (h) The predicted
structures of Abi-1 and NESH. The structures of Abi-1 (green) and NESH (cyan) are presented as a ribbon diagram, being maximally superimposed with
respect to their SH3 domains
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to the leading edge and the formation of Rac-induced pro-
trusions [35]. It is possible that a decreased amount of
PIP3 may cause insufficient WAVE2 complex activation
and/or membrane recruitment. In either case, our results
clearly showed that the NESH/Abi-3-based WAVE2 com-
plex is functionally different from the Abi-1-based one.
It is interesting that the expression of NESH/Abi-3 in-
hibits migration of SRD cells but not NIH3T3 cells in
the wound healing assay. This finding indicates that the
mechanism of cell motility is not identical for these two
types of cells. Ichigotani et al. reported that expression
of NESH/Abi-3 inhibits the motility of human glioblast-
oma (U87MG) cells as well as SRD cells [17]. A possible
difference between these cells and NIH3T3 cells might
be the activation of c-Abl kinase. c-Abl can be activated
downstream of v-Src [36]. In SRD cells that express v-
Src, c-Abl activity may be increased, so that Abi-1 could
serve as an adaptor protein to promote c-Abl-mediated
phosphorylation of cell motility-related proteins in-
cluding WAVE2. Because NESH/Abi-3 does not bind
to c-Abl, it cannot serve as an adaptor for c-Abl. Accord-
ingly, c-Abl-mediated phosphorylation may not be pro-
moted. By contrast, in NIH3T3 cells, the c-Abl-mediated
phosphorylation may not be a major factor controlling cell
motility.
The differences between Abi family proteins are also
clear as to the invadopodia formation in SRD cells.
Matsuda et al. reported that the expression of NESH/
Abi-3 increased the metastasis of SRD cells in the pres-
ence of imatinib mesylate [18]. Our results suggest that
the increase in metastasis they observed may be associ-
ated with an increase in the invadopodia formation po-
tential, because the lateral cellular motility of these
cells decreased during imatinib treatment. In addition,
our results also clarified that this phenomenon is specific
to NESH/Abi-3 among the three Abi proteins. Abi-1 is re-
ported to be involved in the regulation of N-WASP/
WASP [37–39], and other actin regulatory proteins such
as Mena [6] and MIG10 [40]. It is believed that N-WASP/
WASP is critical as an actin polymerization regulator for
invadopodia formation. The functional interaction of
NESH/Abi-3 with these molecules should be examined in
the future.
Replacement of Abi-1 with NESH/Abi-3 reduced inva-
dopodia formation. This may be due to invadopodia for-
mation mediated by Abi1/2-WAVE complex but not by
the NESH/Abi-3-WAVE complex. However, since it has
been reported that the WAVE complex is not implicated
in invadopodia formation, it is more likely that expression
of NESH/Abi-3 reduces Abi-1 and Abi-2 expression,
which normally bind N-WASP and mediate invadopodia
formation. NESH/Abi-3 may not bind N-WASP and
hence may not replace Abi1/2 in invadopodia formation.
Meanwhile, Smith-Pearson et al. disclosed a critical role of
Abl kinases in the matrix degradation and cell invasion
[27]. In SRD cells, Abi-1 and Abi-2 may regulate c-Abl-
mediated phosphorylation, and NESH/Abi-3 may compete
with Abi-1 and/or Abi-2 to inhibit the invadopodia forma-
tion. However, the above hypotheses alone cannot explain
why NESH/Abi-3 promotes the invadopodia formation
when c-Abl is inhibited. One possibility is the existence of
another pathway downstream of the Src activation, this
pathway being negatively regulated by c-Abl. When c-Abl
kinase is inhibited, this pathway may be activated, so that
in the presence of NESH/Abi-3, this pathway may induce
the invadopodia formation. Likewise, a previous study
demonstrated that loss of c-Abl facilitates anchorage inde-
pendence in a cellular context-dependent manner [41].
The existence of a transformation-promoting pathway
negatively regulated by c-Abl may be plausible. In
addition, a recent study showed that Abl kinase inhibitor
treatment promotes invadopodia formation in certain can-
cer cells [42]. In view of the above, it is clinically import-
ant to elucidate the signaling pathway activated in the
presence of the Abl kinase inhibitor.
To date, the physiological function of NESH/Abi-3 re-
mains unclear. NESH/Abi-3 is abundant in the spleen
and thymus among tissues [21]. In addition to HUVEC,
NESH/Abi-3 is expressed in several blood cell lines. In
these cells, some WAVE2 complexes should contain
NESH/Abi-3, which does not seem to respond to c-Abl.
These cells may require two types of WAVE2 complexes
to maintain their actin-based cellular cytoskeleton
organization. In addition, macrophages or endothelial
cells produce podosomes, which are a matrix-degrading
ventral cell surface structure similar to invadopodia.
NESH/Abi-3 might be involved in the podosome forma-
tion in these cells.
In this study, we examined the structural difference
between Abi-1 and NESH/Abi-3. The study involving
chimeric Abi molecules showed the importance of
amino acids 270 to 336 of Abi-1. In the model presented
by Dai and Pendergast [2], the SH3 domain of Abi-2
interacts with the proline-rich region of c-Abl, and
reciprocally, the most N-terminal proline-rich region
of Abi-2 binds to the SH3 domain of c-Abl. Most likely,
Abi-1 interacts with c-Abl in a similar manner. Since nei-
ther a domain structure nor a motif is present in the a.a.
270–336 region of Abi-1, it is unlikely that this inter-
domain region directly interacts with c-Abl. One possible
function of this region is to keep the two c-Abl-binding
domains of Abi-1 (the most N-terminal proline-rich re-
gion and the SH3 domain) at proper positions so that
Abi-1 can bind to c-Abl. Because the amino acid length
between the most N-terminal proline-rich region and the
SH3 domain of NESH/Abi-3 is shorter than that in the
case of Abi-1 or Abi-2, NESH/Abi-3 may not be able to
maintain the conformation that supports the binding to c-
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Abl. According to computer modeling, the distance be-
tween the most N-terminal proline-rich region and the
SH3 domain of NESH/Abi-3 is about 8 Å shorter than
that in the case of Abi-1, which supports the above idea.
Recently, analysis of the crystal structure of the WAVE
complex was reported [43]. In this analysis, an Abi-2 mu-
tant without a C-terminal region including the proline-
rich region and the SH3 domain was used. Thus, it should
be intriguing to determine what effects are exerted on the
structural and functional regulation of the WAVE com-
plex by amino acids 270 to 336 of Abi-1.
Conclusions
In this study, we examined the function of NESH/Abi-3
and compared it with those of Abi-1 and Abi-2. We
showed that the NESH/Abi-3-based WAVE2 complex
could not create lamellipodial protrusions in response to
FN stimulation. In addition, we showed that expression
of NESH/Abi-3, but not Abi-1 or Abi-2, reduced the
formation of invadopodia in v-src-transformed cells,
and increased invadopodia formation when c-Abl was
inhibited. We subsequently defined the regions that de-
termine the functional differences between Abi-1 and
NESH/Abi-3. Our results suggest that NESH/Abi-3
plays a different role from those of the other two mam-
malian Abi proteins in the signaling pathway involving
c-Abl and possibly c-Src.
Methods
Materials
FN and TRITC-phalloidin were purchased from BD Biosci-
ences and Sigma-Aldrich, respectively. The following anti-
bodies were used: anti-Abl (8E9; Pharmingen), anti-FLAG
(M2; Sigma-Aldrich), anti-glutathione S-transferase (GST)
(Santa Cruz Biotechnology), anti-phosphotyrosine (4G10;
Upstate Biotechnology), anti-Abi-1 (1G9; MBL Inc.), anti-
PIR121/Sra-1 (Upstate Biotechnology), anti-Abi-2 (H-50;
Santa Cruz Biotechnology), anti-Arp3 (abcam), anti-Rac
(Upstate Biotechnology), anti-cortactin (Millipore), and
anti-α-tubulin (Sigma-Aldrich) antibodies. A rabbit anti-
WAVE2 antibody was prepared in our laboratory and used
for immunoblotting analysis. A rabbit anti-WAVE2
antibody used for immunofluorescence analysis was a
kind gift from Drs. T. Takenawa and D. Yamazaki. A
rabbit or mouse anti-NESH polyclonal antibody was
previously described [21]. An anti-mouse NESH mono-
clonal antibody was prepared in this study. A cDNA for
mouse NESH (AK008928) were obtained from RIKEN.
The cDNA fragment encoding 204a.a.–367a.a. of mouse
NESH was inserted into an expression vector, pGEX-
4T-1 (Amersham Biosciences). The GST-tagged mouse
NESH fragment was expressed in Escherichia coli cells,
purified, and then injected into BALB/c mice. Hybrid-
oma cells producing antibodies against mouse NESH
were obtained according to the standard protocol. The
obtained monoclonal antibody (2H7) reacts with both
mouse and human NESH, but not Abi-1 or Abi-2.
Cell culture
293T cells were grown in Dulbecco’s modified Eagle’s
medium supplemented with 10 % fetal bovine serum
and antibiotics. NIH3T3 cells were grown in Dulbecco’s
modified Eagle’s medium supplemented with 10 % calf
serum (CS) and antibiotics. v-src-transformed NIH3T3
cells (SRD cells) were grown in DMEM supplemented
with 10 % CS, 1 μg/mL puromycin, and antibiotics.
Establishment of stable cells
The cDNA for each of FLAG-Abi-1, FLAG-Abi-2, FLAG-
NESH, Abi-1, NESH, and chimeric proteins N-1 and N-5
was subcloned into the pCX4bsr vector. To prepare a re-
combinant retrovirus, each plasmid was co-transfected to-
gether with pGP Vector and pE-eco Vector (Takara) into
PLAT-E cells using Fugene 6 (Roche). At 24 h after
the transfection, the medium was changed to fresh.
After an additional 24 h, the supernatant was collected and
passed through a filter of 0.22-μm pore size. The resulting
virus solution was added to NIH3T3 cells. After 24 h incu-
bation, the medium was changed to fresh containing
10 μg/mL blasticidin to establish stable cells expressing
each Abi protein. A mixed population of drug-resistant
cells was used for experiments. The empty vector was used
to establish control cells. The mixed population of drug-
resistant cells was cultured in DMEM supplemented with
10 % CS, 10 μg/mL blasticidin, and antibiotics.
A recombinant retrovirus containing v-src was pro-
duced with the pBabe Puro v-src vector (a kind gift from
T. Akagi), and NIH3T3 cells were infected with the virus
to produce SRD cells. The cDNA for Abi-1, FLAG-Abi-
2, or NESH was subcloned into the pCX4neo vector to
produce the pCX4neo-Abi-1, pCX4neo-FLAG-Abi-2,
or pCX4neo-NESH plasmid. Virus solutions were ob-
tained as described above. Stable SRD cells expressing
Abi-1, FLAG-Abi-2, or NESH were obtained in the
same manner except that 1.6 mg/mL G418 and 1 μg/mL
puromycin were used for selection. A mixed popula-
tion of drug-resistant cells was used. The cells were
maintained in the presence of 1.6 mg/mL G418 and
1 μg/mL puromycin.
Cell-spreading assay
Confluent cells were detached by trypsinization and held
in suspension for 45 min. The resulting cells were plated
onto FN-coated coverslips and then incubated at 37 °C
for the indicated times. Subsequently, the cells were
fixed, washed gently with phosphate-buffered saline, and
then subjected to immunofluorescence analysis.
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Rac-GTPase assay
The CRIB domain of PAK1 (a.a. 67–150) was amplified by
means of a PCR using a human leukocyte cDNA library as
a template. The cDNA encoding the PAK-CRIB was sub-
cloned into the pGEX-2T vector. Expression and purifica-
tion of GST-CRIB were performed in accordance with the
manufacturer’s instructions. Then, 250 μg aliquots of
cellular lysates were incubated for 90 min at 4 °C with the
GST-CRIB immobilized on glutathione beads.
Wound-healing assay
NIH3T3 cells or SRD cells expressing each of the Abi
proteins were plated on FN-coated coverslips while be-
ing kept confluent. The cells were wounded by manual
scraping with a yellow tip. At 0 and 12 h after the scrap-
ing, differential interference contrast images were ob-
tained and the wounded area in each image was
measured using the ImageJ software.
Invadopodia assay
TRITC gelatin-coated dishes were prepared as described
previously [44]. Cells were cultured on the gelatin matrix
for 7 h, fixed with paraformaldehyde, and then stained
with an anti-cortactin antibody. To assess matrix deg-
radation, images were obtained by confocal microscopy.
The gelatin degradation area exhibiting overlapping cor-
tactin staining was quantitated with the ImageJ software.
Imatinib treatment
Cells were incubated in a 5 μM or 10 μM imatinib-
containing medium for 24 h at 37 °C prior to assays. As-
says were performed in the presence of the same con-
centrations of imatinib.
RNA interference
Four siRNAs against mouse c-Abl were obtained from
QIAGEN. After checking their knockdown efficiency,
Mm_Abl1_2 was selected and used for the experiments.
Control SRD cells and SRD cells expressing each of the
Abi proteins were transfected with Mm_Abl1_2 at a final
concentration of 100 nM using Lipofectamine RNAi-
MAX (Life Technologies) according to the manufac-
turer’s protocol. At 72 h after the transfection, the cells
were plated onto TRITC gelatin-coated dishes and ana-
lyzed as described above.
Expression plasmids
The cDNAs for human Abi-1 and human NESH were
described previously [6, 21]. The interactor protein
AblBP4 [Homo sapiens] GenBank: AAD00897.1 (451
a.a.) was hereafter used as the cDNA for Abi-1. This
Abi-1 clone corresponds to isoform 3 described by
Dubielecka et al. [45]. A cDNA for human Abi-2 was
amplified by means of a PCR using a human leukocyte
cDNA library (CLONTECH). The obtained cDNA was
found to be identical to that for abl interactor 2 (acces-
sion number BC001439). A cDNA for human WAVE2
was a kind gift from Dr. Takenawa. pcDNA3 c-Abl was a
kind gift from Dr. David Baltimore. Mammalian expres-
sion plasmids, pEBG (a gift from Dr. Bruce Mayer) and
pFLAG-CMV-6 (Sigma-Aldrich), were used to express
proteins fused with an N-terminal GST and FLAG tag, re-
spectively. Chimeric mutants between Abi-1 and NESH
were produced by PCR and verified by DNA sequencing.
Abi-1/NESH•SH3 was composed of the N-terminal 391
amino acids (a.a.) of Abi-1 and the SH3 domain of NESH
(a.a. 311–366). NESH/Abi-1•SH3 was composed of the N-
terminal 310 a.a. of NESH and the SH3 domain of Abi-1
(a.a. 392–451). Chimeric proteins N-1, N-2, N-3, N-4, and
N-5 were fusion proteins comprising a.a. 1–168, 1–180,
1–199, 1–239, and 1–263 of NESH, and a.a. 174–451,
191–451, 213–451, 270–451, and 336–451 of Abi-1, re-
spectively. The NESH chimera containing a.a. 270–336 of
Abi-1 was created by inserting a.a. 270–336 of Abi-1 be-
tween proline 236 and leucine 237 of NESH/Abi-3. Abi-1
Y213F was created by replacing tyrosine 213 of Abi-1 by a
phenylalanine.
In Vitro binding assay
GST-tagged and FLAG-tagged proteins were expressed
in 293T cells, and pull-down experiments were per-
formed as described previously [6].
Phosphorylation analysis
Phosphorylation analysis was performed as described
previously [6]. Briefly, 293T cells were transfected with
expression plasmids using LipofectAMINE PLUS re-
agent (Invitrogen). At 24 h after the transfection, cells
were lysed in a lysis buffer containing phosphatase in-
hibitors (1 mM sodium orthovanadate and 10 mM so-
dium fluoride), and then analyzed by Western blotting
with an anti-phosphotyrosine antibody. In some experi-
ments, lysates were pulled down and the bound proteins
were analyzed by Western blotting.
Immunoprecipitation
Immunoprecipitation was performed essentially as de-
scribed previously [21]. Briefly, lysates were incubated with
the respective antibodies overnight at 4 °C while rocking.
Then, protein G beads were added, incubated, centrifuged,
and washed. The immunoprecipitated proteins were then
boiled in a sample buffer, subjected to SDS-PAGE, and
transferred onto an Immobilon-P membrane.
Prediction of the three-dimensional structures of Abi-1
and NESH/Abi-3
The three-dimensional structure of the full-length Abi-1
was calculated using the Robetta server [46] in accordance
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with the Rosetta de novo protocol [47, 48]. Using this
structure as a template, the three-dimensional structure of
NESH/Abi-3 was predicted with the Modeller [49] using a
homology modeling protocol. All the calculations for the
prediction of the structures were carried out under default
parameter settings.
Additional file
Additional file 1: Figure S1. (A) One hundred μg of lysates prepared
from NIH 3T3 cells and mouse brain were analyzed by Western blotting
with the indicated antibodies. For Abi-2, two different dilutions of the
antibody were used to obtain the results. Several Abi-1 or Abi-2 bands
observed for the mouse brain lysates may reflect splicing variants, or the
phosphorylation or partial degradation of these proteins. (B) Control
NIH3T3 cells and NIH3T3 cells expressing Abi-1 or NESH were plated onto
FN-coated coverslips, and analyzed as described in Fig. 1a. (C) Quantitative
analysis of the cells in (B). Cells with lamellipodial structures were counted
under a fluorescence microscope. At least 100 cells were analyzed for each
sample. Data represent the means ± S.D. for three independent experiments.
(D) The wound-healing assay was performed using the control NIH3T3 cells
and NIH3T3 cells expressing Abi-1 or NESH, and analyzed as described in
Fig. 1e. (E) Mouse brain lysates were immunoprecipitated with a mouse IgG,
the anti-Abi-1 monoclonal antibody (1G9), or the anti-NESH monoclonal
antibody (2H7). The precipitated proteins were analyzed by Western blotting
with the indicated antibodies. (F) Rac activity assay. Cell lysates of the control
and FLAG-NESH expressing NIH3T3 cells were incubated with GST-CRIB
immobilized on glutathione beads, and then the precipitated proteins were
analyzed by Western blotting with an anti-Rac antibody. To determine the
total amount of Rac, 4 % of each lysate was analyzed (Input). (TIFF 19164 kb)
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